http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-023387-B1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_38649abe9f6e3f5a44eaea8c9b3403ae |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-00 |
| filingDate | 2012-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_185e35b052940edb1bcc118ab4e67999 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f93d781154c2b06bde0e27546062f1bb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ef68c76e5325c197e9593764e23873aa http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9912ff494efa30eb21a5985bc2287be1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c034dfe8c91dec968a0416e0d682040 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_688eb492f8277ee2928aba8eaf189e5d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_deec607782804d0e8d7ec1c1aecac30e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_25a4149dfd00cbafb24811e0092f9a16 |
| publicationDate | 2016-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EA-023387-B1 |
| titleOfInvention | Recombinant plasmid DNA pFK3, provides a synthesis of recombinant peptides RL3, is an analogue of kappa-casein FRAGMENTS OF HUMAN RECOMBINANT STRAIN OF BACTERIA ESCHERICHIA COLI XL1-Blue / pFK3 and recombinant peptides RL3 - ANALOG FRAGMENTS of kappa-casein A person with apoptotic activity against cancer cells |
| abstract | The invention relates to recombinant plasmid DNA, providing an increased yield of recombinant peptide RL3 containing a human kappa-casein fragment, a recombinant strain of Escherichia coli (deposited at CEMTC IHBFM SB RAS under EMTP number 1346), which produces an increased output recombinant, which produces an increased output of recombinant recombinant strain of ICHFM SB RAS under the EMCT 1346, which produces an recombinant strain of recombinant peptide RL3; human kazenin, and recombinant peptide RL3, which has increased apoptotic activity against tumor cells, which consists of three components: N-terminal polyhistidine after sequence MRGSHHHHHHGS, methionine residue introduced into the construct to allow cleavage polyhistidine sequence, and a fragment of human kappa-casein 31 to 102 aa The invention can be used in biotechnology. |
| priorityDate | 2012-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 43.